Literature DB >> 12099729

Apoptosis modulation by mycolic acid, tuberculostearic acid and trehalose 6,6'-dimycolate.

I Nuzzo1, M Galdiero, C Bentivoglio, R Galdiero, C Romano Carratelli.   

Abstract

The object of our study is to demonstrate that some components of M. tuberculosis, such as cord factor or mycolic acid or whole bacteria can prolong cell survival compared to controls. The cells treated with cord factor or mycolic acid at a concentration of 5 microg/ml were 65+/-8% viable reaching 70+/-8% at a concentration of 10 microg/ml. The cells treated with heat killed mycobacteria were 70+/-8% viable; while control cells exhibited a viability 50+/-7%. Conversely, tuberculostearic acid induced early cell death. The results also demonstrated a dose-dependent effect on the viability or induction of macrophage apoptosis. We also showed that prolonged viability of the treated cells with mycolic acid or cord factor (+20+/-4% and +25+/-5%, respectively) was correlated with a significant increase in Bcl-2 expression. The treated cells with whole bacteria presented a Bcl-2 expression of 40+/-6%, while Fas expression was not changed compared to controls. This study confirm that at the site of mycobacterial infection, necrosis, apoptosis or prolonged survival of the cells depend on the quantity and quality of the molecules expressed by the mycobacteria; whether necrosis or apoptosis or prolonged survival is more or less favorable to the host likely depends on several factors regarding the inflammatory and immune response, both markedly stimulated by mycobacteria. Copyright 2002 The British Infection Society.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12099729     DOI: 10.1053/jinf.2002.1001

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  6 in total

1.  An ethA-ethR-deficient Mycobacterium bovis BCG mutant displays increased adherence to mammalian cells and greater persistence in vivo, which correlate with altered mycolic acid composition.

Authors:  Michelle Lay Teng Ang; Siti Zarina Zainul Rahim; Zarina Zainul Rahim Siti; Guanghou Shui; Petronela Dianiškova; Jan Madacki; Wenwei Lin; Vanessa Hui Qi Koh; Julia Maria Martinez Gomez; Sukumar Sudarkodi; Anne Bendt; Markus Wenk; Katarína Mikušová; Jana Korduláková; Kevin Pethe; Sylvie Alonso
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

Review 2.  Vaccines for tuberculosis: novel concepts and recent progress.

Authors:  T Mark Doherty; Peter Andersen
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

3.  Stable extracellular RNA fragments of Mycobacterium tuberculosis induce early apoptosis in human monocytes via a caspase-8 dependent mechanism.

Authors:  Andrés Obregón-Henao; María A Duque-Correa; Mauricio Rojas; Luis F García; Patrick J Brennan; Blanca L Ortiz; John T Belisle
Journal:  PLoS One       Date:  2012-01-09       Impact factor: 3.240

4.  Transposon libraries identify novel Mycobacterium bovis BCG genes involved in the dynamic interactions required for BCG to persist during in vivo passage in cattle.

Authors:  Tom A Mendum; Aneesh Chandran; Kerstin Williams; H Martin Vordermeier; Bernardo Villarreal-Ramos; H Wu; Albel Singh; Alex A Smith; Rachel E Butler; Aravind Prasad; Neeraj Bharti; Ruma Banerjee; Sunitha M Kasibhatla; Apoorva Bhatt; Graham R Stewart; Johnjoe McFadden
Journal:  BMC Genomics       Date:  2019-05-28       Impact factor: 3.969

5.  Relatively low level of antigen-specific monocytes detected in blood from untreated tuberculosis patients using CD4+ T-cell receptor tetramers.

Authors:  Yuhong Huang; Yan Huang; Yimin Fang; Juan Wang; Yan Li; Nan Wang; Jianbo Zhang; Ming Gao; Lirong Huang; Fangfang Yang; Cong Wang; Shuxian Lin; Yanan Yao; Liangliang Ren; Yi Chen; Xuanjing Du; Dan Xie; Rongshun Wu; Kouxing Zhang; Lifang Jiang; Xinbing Yu; Xiaomin Lai
Journal:  PLoS Pathog       Date:  2012-11-29       Impact factor: 6.823

6.  Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target.

Authors:  Sanjib Bhakta; Gurdyal S Besra; Anna M Upton; Tanya Parish; Carolyn Sholto-Douglas-Vernon; Kevin J C Gibson; Stuart Knutton; Siamon Gordon; Rosangela P DaSilva; Matthew C Anderton; Edith Sim
Journal:  J Exp Med       Date:  2004-04-26       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.